BioWorld

Aug. 12, 2003

ViroPharma Licenses CMV Drug From Glaxo For $3.5M Up Front

Traces Of Copper Up Alzheimer's Disease Plaques In Rabbits; How About Human Clinical Trials Soon?

TKT Seeking Partner Following Wyeth's Return Of Factor VIII

Curis Nets $10M Through Private Sale Of Common Stock, Warrants

Other News To Note

Renovis Raises $45M In Series E Round For Product Development

Less than a year after building its pipeline through an acquisition, Renovis Inc. raised $45 million through a Series E round of financing. (BioWorld Today) Read More

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...